Circulating tumor DNA (ctDNA) monitoring in the assessment and prediction of the efficacy of PARP inhibitors (PARPi).
Year: 2025
Type: article
Source: Journal of Clinical Oncology
Authors: Diwei Zhao, Junliang Zhao, Yuanwei Li, Xinyang Cai, Zhenyu Yang, Fangjian Zhou, Yonghong Li, Jun Wang
Institution: Sun Yat-sen University Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4407678499
